10.1159/000093982 104 SevenA.CivelekS.InciE.InciF.KorkutN.BurcakG
Ecnoglutide: Weekly Injectable GLP-1 Agonist Ecnoglutide, a weekly injectable GLP-1 agonist, has demonstrated significant mean reductions in body weight, ranging from 1.57 kg to 2.26 kg at the end of the treatment period
Without looking at labs, body composition trends, liver markers, glucose regulation, thyroid status, menopausal symptoms, gut issues, and medication history, it is easy to oversimplify the problem
Experimental approaches, such as miR-34a modulation, 17-estradiol supplementation, and L-carnitine administration, show promise in mitigating ketamine-induced neurotoxicity (Morgan et al., 2004)